ABSTRACT
INTRODUCTION
Obesity is a condition of abnormal or excessive fat accumulation to the extent that increase the risk of suffering from type II diabetes mellitus, cardiovascular disease, cancer and renal diseases. Obesity is considered as a result of long-term energy imbalance and it has been linked to increased dietary intake, especially saturated fat, and sedentary lifestyle
(1) . Obesity in animal model is usually taken as any significant increase in body weight or energy content relative to control animals. The induction of obesity may be performed in animals by neuroendocrine, dietary or genetic changes (2) . Oxidative stress is loss of the equilibrium between the generation of oxidants and antioxidant systems. Oxidative stress is an important mediator of damage to cell structures including cell membrane, lipids, nucleic acids and proteins. The major aldehyde product of lipid peroxidation is malondialdehyde (MDA) (3) . In the kidney, a number of pathways generate reactive oxygen species (ROS) such as high intracellular glucose level, polyol pathway activation, inducible nitric oxide synthase (iNOS) and lipotoxicity contribute to localized tissue oxidative stress (4) . Aldose reductase (AR), a key enzyme in the polyol pathway, catalyzes reduction of glucose to sorbitol whose intracellular accumulation might cause renal tubular reabsorption dysfunction (5) . Quality and quantity of dietary fat had different effects on the pathogenesis of obesity and its complications. Modification of fatty acid composition and/or their location in the glycerol backbone can improve the physical and/or physiological properties of dietary lipids, in particular, ω-3 polyunsaturated fatty acids (ω-3 PUFA) (6) . Omega-3 poly unsaturated fatty acids from fish oil eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are more biologically potent than those from plants. Fish oil ω-3 PUFA affect eicosanoid metabolism and cytokine production (7) . Porpoise oil contains structural lipids as combination of isovaleric acid (iso-C5) and ω-3 PUFA (8) . Therefore, our aim was to develop obesity in rat by high fat diet (HFD) and to estimate the biochemical changes and mechanisms that link obesity with altered renal function to shed light on the effect of obesity on kidney and its improvement with porpoise oil to give a new hope for controlling the effect of obesity on the kidney functions.
MATERIAL & METHODS
The current work was carried out in accordance with the guidelines of the Ethical Committee of Medical Research of Faculty of Medicine Tanta University. All chemicals were obtained from Sigma Chemical Company, Bio-diagnostic Dokki, Giza, Egypt, Diamond Diagnostic, Egypt, Spinreact, Egypt and Sigma Scientific Service, Egypt. All the remaining chemicals were of the highest analytical grade. All the solutions used for enzyme assays were prepared using deionized water to eliminate trace metal contaminations.
The present study was carried out on 40 white male albino rats their weight ranged 110-116 grams. During the study, the animals were kept in wire mesh cages with ad libitum access to water. The room temperature was about 22-24°C and the animals were exposed to 12:12 hours light dark cycles. The animals were randomly divided into four equal groups. All animals were given one week to acclimate to lab conditions, during that time they were maintained on ad libitum (laboratory chow and water). Group I (control group): Ten rats given control diet (low fat diet), 10.6% fat, 59.7% carbohydrate and 27.3% protein during the entire study (12 weeks). Composition of the control diet (g/kg diet) was according to the formula of Dourmashkin et al. (9) . Group II (obese group): Ten rats given HFD, 53.15% fat, 27.17% carbohydrate and 19.68% protein during the entire study (12 weeks). Composition of the HFD (g/kg diet) was according to the formula of Dourmashkin et al. (9) . Control diet and HFD constituents were purchased from El-Gomhoria Company, Cairo, Egypt. High fat diet was preserved at 4°C until used. Obesity was induced in 12 weeks. Group III: Ten rats received HFD for 12 weeks with porpoise oil intake from the start with a dose of I ml/kg/day by oral administration through nasogastric tube. Group IV: Ten rats received the high fat diet for 12 weeks followed by porpoise oil intake with a dose of I ml/kg/day by oral administration through nasogastric tube for another 4 weeks with HFD.
Sampling and tissue preparation:
By the end of the experimental period, all fasting rats (8-12 hours) were sacrificed and blood and tissue samples were collected.
Blood sampling:
Sera were separated and stored in aliquots at -70°C till used for estimation of fasting plasma glucose by oxidase method using assay kit (Biodiagnostic, Egypt), serum urea and creatinine by colorimetric methods using commercial kits (Diamond Diagnostic, Egypt), total lipid profile including total cholesterol (TC), triglycerides (TG) and highdensity lipoprotein cholesterol (HDL) by colorimetric methods using assay kits (Biodiagnostic, Egypt 
RESULTS
Figure (1) shows a comparison of body weight (BW) gain of rats in grams throughout the experimental study each separated by 2 weeks interval among all studied groups using ANOVA-test. There was significant difference between them (p-value <0.05) with significantly higher increase in the body weights of the group receiving HFD alone more than control group. Administration of porpoise oil minimizes the increase in body weight. Table ( 1) shows that body, kidney and visceral adipose tissue weights increased significantly in rats on the HFD alone compared with body weight of control group, while treatments with porpoise oil significantly reduced this gain during the treatment period with porpoise oil. Table ( 2) shows significant increase in urinary albumin level, serum levels of urea, creatinine, TAG, total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C) with low level of high density lipoprotein-cholesterol (HDL-C) in rats on the HFD alone compared with control group. While, administration of porpoise oil significantly improved these changes with more improvement occurs in the group received porpoise oil from the start of induction of obesity. Table ( 3) shows that serum levels of glucose, insulin, MDA and FFA were significantly raised as well as the calculated HOMA-IR, while NO levels were significantly lowered in rats on the HFD alone compared with control group. These alterations were ameliorated by administration of porpoise oil with more improvement occurs in the group received porpoise oil from the start of induction of obesity. Table ( 4) shows that tissue levels of TG, FFA and MDA as well as AR activity were significantly raised, while tissue NO level was significantly lowered in rats on the HFD alone compared with control group. These alterations were ameliorated by administration of porpoise oil with more improvement occurs in the group received porpoise oil from the start of induction of obesity. 
DISCUSSION
Obesity is a complex metabolic disorder characterized by an excess of body fat and represent one of the major public health problems, dietary factors, particularly the consumption of HFD is considered a risk factor for its development (19) . Hypercaloric diet is the simplest obesity-induction model, and closely resembles the reality of obesity in humans. Rat model is a useful tool for inducing experimental obesity as they will readily gain weight when fed HFD containing more saturated fat, and due to great similarity between the genomes of rodents and humans (20) . Obesity is an important independent risk factor for kidney disease because of renal intracellular lipid accumulation, obesity associated hypertension, hyperglycemia, dyslipidemia and oxidative stress (21) . In the present study, a HFD containing 53.15% of its calories from fat as vegetable oil was used to induce obesity in albino rats. Obesity was induced within 12 weeks. The body, kidney and visceral adipose tissue weights gained by rats on HFD formula, was significantly more than that gained by those on control diet (10.6% of its calories is derived from fat). This may be due to HFD-induced hyperphagia and the high energy value of HFD (22) , such result is in accordance with that of Akiyama et al. (23) . Visceral and renal fat accumulation through consumption of HFD may contribute to increased intra-renal pressure and physically compress the kidneys (24) . Our results showed a significant decrease in whole body, kidney and visceral adipose tissue weights from oral administration of porpoise oil especially in the group fed porpoise oil from the start of obesity induction (group 3) than those fed porpoise oil for 4 weeks after obesity induction (group 4). Mathai et al. (25) reported that ω-3 PUFA supply may control the food intake, especially in conditions of reduced glucose availability in the cells as in diabetes mellitus. Porpoise oil supplementation produced significant decreases in serum levels of TC, TG, LDL-C, serum and tissue FFA and renal tissue TG, while there was significant increases in HDL-C in obese rats with more improvement in group fed porpoise oil from the start of obesity induction than group fed porpoise oil for 4 weeks after induction. From the current data, it could be suggested that porpoise oil has hypolipidemic action. This could be explained by suppression of hepatic lipogenesis, enhanced fatty acid oxidation in the liver and skeletal muscle as well as enhancing the flux of glucose to glycogen by ω-3 PUFA content of porpoise oil (33) . These studies were extensively reviewed and reported (34,35) . The current study also revealed higher level of urinary albumin, fasting blood glucose, fasting plasma insulin and HOMA-IR in rats on HFD than the control ones, which parallels the results obtained by Lu et al. (36) and Afonso et al.
(37) These results could be attributed to nutrient overload, inflammation, oxidative stress, deficiency of active insulin receptors causing hyperinsulinemia 38 . Hyperinsulinemia causes downregulation of the insulin receptors, later on exhaustion of the β cell function and overt type II diabetes mellitus occurs. Increasess in insulin, FFA, and/or glucose levels cause more oxidative stress and more ionpairment of both insulin action and secretion
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. Porpoise oil administration to HFD fed rats reduced significantly urinary albumin, blood glucose and plasma insulin level and HOMA-IR index, with more improvement in group fed porpoise oil from the start of induction than group fed porpoise for 4 weeks after induction. These results are in accordance with those obtained by Storlien et al. (40) . This effect may be due to improvement of insulin action by ω-3 PUFA contents of porpoise oil, through suppression of hepatic lipogenesis, reducing the hepatic output of TG, inducing FA oxidation, decreasing inflammatory cytokines, reducing expression of iNOS, decreasing ROS production and improving glucose uptake and glycogen synthesis (41,42) . Lifestyle and diet play an important role in the development of kidney disease. The obese rats showed a highly significant increase in the concentration of serum urea and creatinine in HFD group compared with the control group, a finding which is in agreement with the result of Cindik et al. (40) . The oral administration of porpoise oil led highly significantly decrease in serum levels of urea and creatinine in group fed porpoise oil from the start of induction than group fed porpoise for 4 weeks after obesity induction. The effect of porpoise oil on renal lipid metabolism could serve as a new therapeutic approach, as it counters the renal changes associated with metabolic syndrome, and has beneficial effects on renal function.
Nitric oxide is synthesized continuously in the endothelium from L-arginine by endothelial nitric oxide synthase (eNOS). It plays an important role in maintaining basal vascular tone, inhibits platelet and leukocyte adhesion to vascular endothelium, and inhibits proliferation of smooth muscle cells through its effect on the soluble Guanylate Cyclase signaling pathway (44) . It plays an important role in the regulation of renal blood flow to the renal medulla and in the tubular regulation of sodium excretion.
(45) . The current study revealed lower level of NO in serum and kidney tissue in rats on HFD than the control ones. This may be due to NO inactivation by ROS and decreased NO synthase activity. Nitric oxide deficiency may contribute to renal vascular congestion and the renal dysfunction progression (46) . The oral administration of porpoise oil led to highly significantly increase in serum and kidney tissue NO levels in the group fed porpoise oil from the start of obesity induction than group fed porpoise for 4 weeks after obesity induction. This effect may be due to increased vascular synthesis of NO, decreased oxidative stress, improvement of dyslipidemia and hyperglycemia associated with administration of porpoise oil that results in replenish of NO level to normal (47) . Aldose reductase catalyzes reduced nicotinamide adenine dinucleotide phosphate (NADPH) dependent reduction of glucose to sorbitol. This current study revealed higher level of renal tissue AR activity in rats on HFD than the control ones. This may be due to hyperglycemia and increased intracellular glucose level which activate polyol pathway that cause accumulation of sorbitol (48) . Sorbitol decreases the activity of Na + -K + -ATPase as well as increased expression of cytokines and proteins including transforming growth factor (TGF-β) and fibronectin which cause thickening of the glomerular basement membrane and renal tubular reabsorption defect 48 . The oral administration of porpoise oil led to highly significant decrease in kidney tissue AR activity in the group fed porpoise oil from the start of obesity induction than group fed porpoise oil for 4 weeks after obesity induction this effect is due to decreased blood glucose level and the improvement in insulin sensitivity of the glomerular cells (49) . Obesity per se may induce systemic oxidative stress through increased ROS production via obesity associated hyperglycemia, hyperinsulinemia, FFA, increased NADPH oxidase and decreased antioxidant enzymes. ROS generated in oxidative stress activate nuclear factor kappa-B (NF-ĸB) that triggers the transcription of several mediators of inflammation with more ROS genĸ eration (50) . This current study also revealed higher level of MDA in serum and kidney tissue from HFD rats than the control ones, indicating oxidative stress in the renal tissue which causes lipid peroxidation. Our results are in agreement with the results of Olusi et al. (51) and Amirkhizi et al. (52) . The oral administration of porpoise oil showed that MDA in serum and kidney tissue were highly significantly decreased in group fed porpoise oil from the start of obesity induction than group fed porpoise oil for 4 weeks after obesity induction this can be explained by amelioration of oxidative stress state by porpoise oil administration.
From these data it could ve suggested that HFD might cause renal oxidative stress and renal lipotoxicity which are associated with lower renal NO, so HFD can initiate glomerular vasoconstriction and renal lipotoxicity favouring nephropathy.
CONCLUSION
Collectively, feeding HFD to rats resulted in significant elevation in body weight, visceral fat weight, blood levels of glucose, insulin , TAG, TC, LDL-C, serum and renal tissue MDA, serum and renal tissue FFA, renal tissue TAG and AR activity with significant decrease in serum and renal NO levels in our obesity model. All of these parameters implicated in renal disorders and produce adverse effects on kidney.
Administration of porpoise oil improved these changes as it improves blood glucose level, insulin sensitivity, dyslipidemia, lipid peroxidation which is cytotoxic by reducing free-radical production and by increasing NO production/availability. NO improves renal vascular tone so that kidney function is improved. Porpoise oil can protect the kidney from deleterious effect of bad feeding habit and obesity but further studies is required to explain whether these effects is due to ω-3 PUFA component alone or other component of porpoise share these effects.
Our data offer novel insights into potential mechanisms of renal dysfunction in obesity and demonstrate the efficacy of porpoise oil in renal protection and weight management.
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